Stenabolic
Also known as: SR9009, SR-9009
Classification
Unknown
Regulatory Status
n/a
Sources
3
Review
n/a
Overview
Stenabolic (SR9009) is a synthetic REV-ERB agonist studied in mice for circadian and metabolic effects (energy expenditure, fat mass). Human pharmacokinetics, efficacy, and safety are not established.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
circadian-clockenergy-expenditureREV-ERB agonismREV-ERB-alphaREV-ERB-beta
Interactions & cautions
Drug interactions
other metabolic modulators, SARMs, or unapproved performance agents — Unstudied combined risk. (review)
These are observational flags for review, not individualized instructions.
Sources
- https://www.nature.com/articles/nature11030 (opens in a new tab)
- https://pubchem.ncbi.nlm.nih.gov/compound/57394020 (opens in a new tab)
- https://www.drugs.com/wada/s4-hormone-and-metabolic-modulators.html
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw